Humasis Co Ltd
KOSDAQ:205470
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Humasis Co Ltd
Other Receivables
Humasis Co Ltd
Other Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Humasis Co Ltd
KOSDAQ:205470
|
Other Receivables
₩1.4B
|
CAGR 3-Years
-48%
|
CAGR 5-Years
23%
|
CAGR 10-Years
85%
|
|
|
Suheung Co Ltd
KRX:008490
|
Other Receivables
₩14.2B
|
CAGR 3-Years
24%
|
CAGR 5-Years
38%
|
CAGR 10-Years
20%
|
|
|
SD Biosensor Inc
KRX:137310
|
Other Receivables
₩30.6B
|
CAGR 3-Years
-45%
|
CAGR 5-Years
102%
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Other Receivables
₩4.2B
|
CAGR 3-Years
97%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Other Receivables
₩5.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
2%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Other Receivables
₩1.8B
|
CAGR 3-Years
128%
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
|
Humasis Co Ltd
Glance View
Humasis Co., Ltd. engages in developing rapid test kits and point-of-care testing instruments. The company is headquartered in Anyang, Gyeonggi-Do. The company went IPO on 2014-12-01. The firm is engaged in the manufacture and sale of immunoquantitative analysis devices, myocardial infarction test equipment, infectious disease detection devices, hormone test devices, cancer marker test devices and other products. In addition, the Company is engaged in the research and development of biomaterials and other products. The firm sells its products within domestic market and to overseas markets. The firm was established in 2000 and is located in Gunpo-si, Gyeonggi-do, South Korea.
See Also
What is Humasis Co Ltd's Other Receivables?
Other Receivables
1.4B
KRW
Based on the financial report for Sep 30, 2025, Humasis Co Ltd's Other Receivables amounts to 1.4B KRW.
What is Humasis Co Ltd's Other Receivables growth rate?
Other Receivables CAGR 10Y
85%
Over the last year, the Other Receivables growth was -63%. The average annual Other Receivables growth rates for Humasis Co Ltd have been -48% over the past three years , 23% over the past five years , and 85% over the past ten years .
